Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pediatric Cancer Late Effects

Lisa Diller

MD

🏢Dana-Farber/Boston Children's Cancer and Blood Disorders Center🌐USA

Chief Medical Officer and Vice Chair of Clinical Affairs, Pediatrics

70
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Lisa Diller is a pioneer in pediatric cancer survivorship at Dana-Farber/Boston Children's who established one of the first comprehensive survivorship programs for childhood cancer survivors transitioning to adult care. Her research on neurocognitive late effects, Li-Fraumeni syndrome cancer surveillance, and the challenges of transition from pediatric to adult survivorship care has shaped clinical practice. Her advocacy for systematic survivorship care has been instrumental in establishing survivorship as a distinct discipline in pediatric oncology.

Share:

🧪Research Fields 研究领域

Survivorship program development
Young adult cancer survivors
Transition of care survivorship
Li-Fraumeni syndrome surveillance
Neurocognitive late effects

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Lisa Diller 的研究动态

Follow Lisa Diller's research updates

留下邮箱,当我们发布与 Lisa Diller(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment